GRCE Grace Therapeutics, Inc.
Nasdaq · SEC CIK 1444192 · EDGAR
- Bought, last 12 months
- $301.8K 4 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 62 since 2021-11-16, latest 2026-09-23 18:19
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kohli Prashant | CEO, Dir | $214.0K | — |
| Opaleye Management Inc. | 10% | $87.8K | — |
Transactions 6
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-09-23 18:19 | 2026-09-21+ | GRCE | Opaleye Management Inc. | 10% | P - Purchase | $2.10 | +15.1K | 2.86M | +0.5% | +$31.7K |
| MI | 2026-09-10 16:05 | 2026-09-08+ | GRCE | Opaleye Management Inc. | 10% | P - Purchase | $2.09 | +15.2K | 2.78M | +0.6% | +$31.9K |
| 2026-09-10 07:30 | 2026-09-09 | GRCE | Kohli Prashant | CEO, Dir | P - Purchase | $2.14 | +100.0K | 121.4K | +468% | +$214.0K | |
| I | 2026-08-19 07:44 | 2026-08-14 | GRCE | Opaleye Management Inc. | 10% | P - Purchase | $2.09 | +11.6K | 2.76M | +0.4% | +$24.2K |
| DI | 2023-09-27 | 2023-09-25 | GRCE | Kavuru Vimal | Dir, 10% | P - Purchase | $1.85 | +676.4K | 1.19M | +132% | +$1.25M |
| 2023-09-05 | 2023-08-31 | GRCE | Olds Donald | Dir | P - Purchase | $2.05 | +381 | 381 | New | +$781.05 |